Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells
/in International Publications, Newcastle Disease Virus /von 2004-11-01 / Cancer Res. 2004 Nov;64(21):8057-61The role of the immune system in the control of hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2004-11-01 / Eur J Gastroenterol Hepatol 2004 Nov;16(12):1257-60Immunotherapeutic strategies for hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2004-11-01 / Gastroenterology 2004 Nov;127(5 Suppl 1):S232-41Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory
/in International Publications, Newcastle Disease Virus /von 2004-10-30 / Cancer Immunol. Immunother. 2005 Jun;54(6):587-98Phase I/II trial of melanoma patient-specific vaccine of proliferating autologous tumor cells, dendritic cells, and GM-CSF: planned interim analysis
/in International Publications, Malignant Melanoma /von 2004-10-01 / Cancer Biother. Radiopharm. 2004 Oct;19(5):658-65Dendritic cells as vectors for immunotherapy of tumor and its application for gastric cancer therapy
/in Gastric Cancer, International Publications /von 2004-10-01 / Cell. Mol. Immunol. 2004 Oct;1(5):351-6Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit
/in Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease Virus /von 2004-09-27 / J. Clin. Oncol. 2004 Nov;22(21):4272-81Dendritic cell-based immunotherapy in thyroid malignancies
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2004-09-01 / Curr. Drug Targets Immune Endocr. Metabol. Disord. 2004 Sep;4(3):245-51[Immunotherapy–perspectives in therapy of ovarian carcinomas]
/in International Publications, Ovarian Cancer /von 2004-09-01 / Ceska Gynekol 2004 Sep;69(5):372-5
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de